Search clinical trials for: CD4 /CD25 Cells

Total 11638 results

Merck Sharp & Dohme LLC

Completed

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

HIV Infections

United States
The Immune Response Corporation

Completed

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

Multi-Drug Resistant Hiv-1 Infection | HIV-1 Infection

United States
The Immune Response Corporation

Completed

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

HIV Infections

United States
National Cancer Institute (NCI)

Terminated

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

Metastatic Melanoma | Metastatic Renal Cancer

United States
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group

Completed

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

HIV Infection

United States
Hospital Clinic of Barcelona

Terminated

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

HIV Infection

Spain
Vanderbilt University
National Institutes of Health (NIH)

Completed

Optimizing Integrated PMTCT Services in Rural North-Central Nigeria

HIV | Suspected Damage to Fetus From Viral Disease in the Mother

Nigeria, Niger
Tehran University of Medical Sciences

Completed

Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients

Relapsing Remitting Multiple Sclerosis

Iran, Islamic Republic of
University Hospital Birmingham NHS Foundation Trust
Merck Sharp & Dohme LLC

Recruiting

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis (REACTIVAS)

ANCA Associated Vasculitis

United Kingdom
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
Harvard School of Public Health (HSPH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana

HIV Infection | Pregnancy

Botswana
Mekelle University

Unknown

Effects of Aerobic Exercise on CD4 Count,Viral Load,Selected Psycho-social Trait

HIV
Centre Hospitalier Universitaire de Nīmes
Institut de Génétique Moléculaire de Montpellier

Recruiting

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment (RESERVIH32)

HIV-1-infection

France
National Institute of Allergy and Infectious Diseases...

Completed

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

HIV Infections | Cytomegalovirus Infections

United States
Aulos Bioscience, Inc.

Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Metastatic Cancer | Advanced Solid Tumor

Australia, United States
National Cancer Institute (NCI)

Completed

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Prostatic Neoplasms | Prostate Cancer | Neoplasms, Prostate

United States
University of Washington
Merck Sharp & Dohme LLC

Terminated

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 (UW PIC 330)

Human Immunodeficiency Virus

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery. (POIR)

Lung Cancer | Surgery

France
Beijing 302 Hospital

Unknown

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Human Immunodeficiency Virus

China
National Institute of Allergy and Infectious Diseases...
Biogen

Terminated

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

Acquired Immunodeficiency Syndrome | Resistance

Uganda
Juan A. Arnaiz

Completed

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl (ADVANZ-3)

HIV Infections

Spain
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Glaxo Wellcome

Completed

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

HIV Infections

United States
University of Roma La Sapienza
Istituto Superiore di Sanità

Unknown

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

HIV Infection

Italy
University of Nebraska
Sanofi; National Institute of Neurological Disorders and Stroke (NINDS); Nebraska...

Completed

Leukine (Sargramostim) for Parkinson's Disease

Parkinson's Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

HIV Infections

United States
Johann Wolfgang Goethe University Hospital

Completed

Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section

Human Immunodeficiency Virus

Germany
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals (CARegT1D)

Type 1 Diabetes

France
National Institute on Drug Abuse (NIDA)

Completed

Cognitive Behavioral Stress Management for HIV+ Drug Abusers

HIV/AIDS | Drug Abuse | Alcohol Abuse
Pfizer

Completed

Drug Drug Interaction Study Of Crizotinib With Esomeprazole.

Healthy

Belgium
National Cancer Institute (NCI)

Completed

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

HIV Infection

United States
Pharmacia and Upjohn

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of Two Anti-HIV Drug Combinations

HIV Infections

United States, Puerto Rico
American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

HIV Infections

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Affini-T Therapeutics, Inc.

Active, not recruiting

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Other Skin

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Immuno-US

Completed

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

HIV Infections

United States
Medical University of Graz

Completed

HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem. (CIRAST HHV-6)

Allogeneic Stem Cell Transplantation
Hospital Clinic of Barcelona

Completed

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

HIV Infections

Spain
Community Research Initiative of New England

Completed

A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection

HIV Infections

United States
University of Modena and Reggio Emilia

Completed

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

HIV Infection

Italy
Therapeutic Concepts

Completed

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)

HiV1- Positive

United States
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Human Immunodeficiency Virus (HIV)

United States
US Biotest, Inc.
Tarix Pharmaceuticals

Terminated

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

HIV Infections

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Terminated

MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection

HIV Infections

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.

Completed

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

Risk Behavior | HIV | Medication Adherence

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART

HIV-1 Infection

United States
University College Dublin
St Vincent's University Hospital, Ireland; University of Dublin, Trinity College

Completed

Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome (CISAVID)

Multiple Sclerosis | Clinically Isolated Syndrome

Ireland

3

Subscribe